Ventricular Assist Device Implantation and Bariatric Surgery: A Route to Transplantation in Morbidly Obese Patients with End-Stage Heart Failure.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
pubmed:
24
7
2020
medline:
27
4
2021
entrez:
24
7
2020
Statut:
ppublish
Résumé
We reviewed our experience of morbidly obese patients with end-stage heart failure that underwent left ventricular assist device (LVAD) implantation. From January 1, 2008 to January 1, 2018, 240 adult LVADs were implanted at our center. We reviewed the cases of patients presenting with end-stage heart failure and morbid obesity (preoperative body mass index [BMI] ≥ 35 kg/m2) who underwent LVAD-alone, and compared that to a group that underwent LVAD and bariatric surgery (laparoscopic sleeve gastrectomy [LSG]) as a means for weight reduction. Demographic characteristics, perioperative details, BMI, and status of transplant candidacy were recorded. Statistical analysis was performed (SPSS version 25) with χ2 analysis, Kaplan-Meier survival analysis, regression analysis, and Student's t-test. Twenty-nine patients met criteria and underwent LVAD implantation. Fifteen patients underwent LVAD-alone. Fourteen patients underwent LVAD + LSG. Both groups showed good survival outcomes, LVAD-alone (88.9 ± 5.9 months) versus LVAD +LSG (96.1 ± 12.4 months) but were not significantly different. However, we did note that more patients in the LVAD + LSG group were bridged to heart transplantation (p < 0.001). LVAD-alone and/or LVAD + LSG are both technically feasible and effective treatment options for the long-term survival of morbidly obese patients with end-stage heart failure. Combining LVAD + LSG can help bridge patients to heart transplantation.
Identifiants
pubmed: 32701629
pii: 00002480-202102000-00009
doi: 10.1097/MAT.0000000000001212
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
163-168Informations de copyright
Copyright © ASAIO 2020.
Déclaration de conflit d'intérêts
All of the authors including Eric I. Jeng, Amber Miller, Jeffrey Friedman, Stephen Tapia-Ruano, Kevin Reilly, Alex Parker, Juan Vilaro, Juan Aranda, Thomas M. Beaver, George J. Arnaoutakis, Charles Klodell, and Mustafa Ahmed are in agreement with the content in the manuscript. There are no sources of financial support in the form of grants, equipment, and/or pharmaceutical items for this research. There are no potential conflicts of interest. It has been accepted as an abstract to ISHLT Montreal, Canada 2020, but not been published as a manuscript previously and is not currently under consideration elsewhere.
Références
Roger V. Epidemiology of Heart Failure. Circ Res. 2013; 1136646–659
Luepker RV. Epidemiology of heart failure. In: Congestive Heart Failure and Cardiac Transplantation: Clinical, Pathology, Imaging and Molecular Profiles. 2017Springer International Publishingpp. 93–102. https://doi.org/10.1007/978-3-319-44577-9_6
Braunwald E. Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997; 337:1360–1369
Engin A. The Definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol. 2017; 960:1–17
Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002; 347:305–313
Lund LH, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report—2013; Focus Theme: Age. J Hear Lung Transplant. 2013; 3210951–964
Miniati DN, Robbins RC. Heart transplantation: a thirty-year perspective. Annu Rev Med. 2002; 53:189–205
Everly MJ. Cardiac transplantation in the United States: an analysis of the UNOS registry. Clin Transpl. 200835–43
Miller LW, Pagani FD, Russell SD, et al.; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007; 357:885–896
Birks EJ, George RS, Hedger M, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation. 2011; 123:381–390
Weiss ES, Allen JG, Russell SD, Shah AS, Conte JV. Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation. J Heart Lung Transplant. 2009; 28:1150–1157
Kocher AA, Ankersmit J, Khazen C, et al. Effect of obesity on outcome after cardiac transplantation. Transplant Proc. 1999; 31:3187–3189
Butler J, Howser R, Portner PM, Pierson RN III. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg. 2005; 79:66–73
Musci M, Loforte A, Potapov EV, et al. Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg. 2008; 86:1236–1242
Bergenfeldt H, Stehlik J, Höglund P, Andersson B, Nilsson J. Donor–recipient size matching and mortality in heart transplantation: Influence of body mass index and gender. J Hear Lung Transplant. 2017; 369940–947
Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995; 92:3593–3612
Grady KL, White-Williams C, Naftel D, et al. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant. 1999; 18:750–763
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007; 132:2087–2102
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US Adults, 1999–2010. JAMA. 2012; 3075491
Pi-Sunyer FX. The medical risks of obesity. Obes Surg. 2002; 12(Suppl 1): 6S–11S
Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002; 162:1867–1872
Billington C, Epstein L, Goodwin N, Hill J, Pi-Sunyer FX. Overweight, obesity, and health risk. Arch Intern Med. 2000; 1607898–904
Pasulka PS, Bistrian BR, Benotti PN, Blackburn GL. The risks of surgery in obese patients. Ann Intern Med. 1986; 104:540–546
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999; 341:1097–1105
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292:1724–1737
Sarela AI, Dexter SP, O’Kane M, Menon A, McMahon MJ. Long-term follow-up after laparoscopic sleeve gastrectomy: 8-9-year results. Surg Obes Relat Dis. 2012; 8:679–684
Sampalis JS, Sampalis F, Christou N. Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity. Surg Obes Relat Dis. 2006; 2:587–591
Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008; 4:159–64. discussion 164
Porubsky M, Powelson JA, Selzer DJ, et al. Pancreas transplantation after bariatric surgery. Clin Transplant. 2012; 26:E1–E6
Wikiel KJ, McCloskey CA, Ramanathan RC. Bariatric surgery: a safe and effective conduit to cardiac transplantation. Surg Obes Relat Dis. 2014; 10:479–484
Jhaveri RR, Pond KK, Hauser TH, et al. Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery. Surg Obes Relat Dis. 2009; 5:648–652
Garza CA, Pellikka PA, Somers VK, et al. Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am J Cardiol. 2010; 105:550–556
McCloskey CA, Ramani GV, Mathier MA, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis. 2007; 3:503–507
Iyengar S, Leier CV. Rescue bariatric surgery for obesity-induced cardiomyopathy. Am J Med. 2006; 119:e5–e6
Ristow B, Rabkin J, Haeusslein E. Improvement in dilated cardiomyopathy after bariatric surgery. J Card Fail. 2008; 14:198–202
Chaudhry UI, Kanji A, Sai-Sudhakar CB, Higgins RS, Needleman BJ. Laparoscopic sleeve gastrectomy in morbidly obese patients with end-stage heart failure and left ventricular assist device: medium-term results. Surg Obes Relat Dis. 2015; 11188–93
Jeng EI, Aranda JM Jr, Ahmed M, Klodell CT. Left Ventricular assist device and bariatric surgery: a bridge to heart transplant by weight and waiting time reduction. J Card Surg. 2016; 31:120–122
Leviner DB, Keidar A, Ben-Gal T, Medalion B. Cardiac function recovery following LVAD implantation and bariatric surgery in a morbidly obese patient. J Card Surg. 2014; 29:740–742
Thompson K, Dhesi P, Nguyen D, Czer L, Moriguchi J, Schwarz E. Evaluation of the HeartMate II™ left ventricular assist device in obese heart failure patients: effects on weight loss. Ann Transplant. 2011; 16:63–67
Nelson EW, Heinke T, Finley A, et al. Management of LVAD patients for noncardiac surgery: a single-institution study. J Cardiothorac Vasc Anesth. 2015; 29:898–900
Ahmed M, Le H, Aranda JM Jr, Klodell CT. Elective noncardiac surgery in patients with left ventricular assist devices. J Card Surg. 2012; 27:639–642
Degnan M, Brodt J, Rodriguez-Blanco Y. Perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery. Ann Card Anaesth. 2016; 19:676–686
Rose EA, Gelijns AC, Moskowitz AJ, et al.; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001; 345:1435–1443
Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. J Thorac Cardiovasc Surg. 2013; 145:566–73. discussion 573
Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006; 3689536666–78
Ramani GV, McCloskey C, Ramanathan RC, Mathier MA. Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol. 2008; 31:516–520